Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4207190
Max Phase: Preclinical
Molecular Formula: C18H22O2
Molecular Weight: 270.37
Molecule Type: Small molecule
Associated Items:
ID: ALA4207190
Max Phase: Preclinical
Molecular Formula: C18H22O2
Molecular Weight: 270.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(CCCCc2ccc(OC)cc2)cc1
Standard InChI: InChI=1S/C18H22O2/c1-19-17-11-7-15(8-12-17)5-3-4-6-16-9-13-18(20-2)14-10-16/h7-14H,3-6H2,1-2H3
Standard InChI Key: YYHKGSBCQXPZOP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 270.37 | Molecular Weight (Monoisotopic): 270.1620 | AlogP: 4.27 | #Rotatable Bonds: 7 |
Polar Surface Area: 18.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.08 | CX LogD: 5.08 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.70 | Np Likeness Score: -0.05 |
1. McLane RD, Le Cozannet-Laidin L, Boyle MS, Lanzillotta L, Taylor ZL, Anthony SR, Tranter M, Onorato AJ.. (2018) Synthesis and PGE2 inhibitory activity of novel diarylheptanoids., 28 (3): [PMID:29290543] [10.1016/j.bmcl.2017.12.046] |
Source(1):